title: Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine.
abstract: The effect of selective dopamine receptor blockade on epileptic activity was tested in rats, using the lithium-pilocarpine seizure model. One day after lithium pretreatment, systemic administration of the dopamine D1 antagonist, SCH 23390, prevented the convulsive activity induced by either 10 or 15 mg/kg of pilocarpine in a dose-dependent manner as revealed by behavioral and electroencephalographic alterations. No anticonvulsant effect was observed when SCH 23390 was injected at the same time as lithium and 24 h prior to pilocarpine. Furthermore, the D2 antagonists, raclopride and haloperidol, potently reduced the threshold for convulsions induced by 10 mg/kg of pilocarpine, following lithium pretreatment. Neither dopamine D1 nor D2 antagonists altered the limbic stereotypies induced by pilocarpine, supporting the view that the dopamine system is primarily involved in the mechanisms of convulsion generation and seizure spreading. These results indicate that dopamine receptor subtypes exert opposite functions on the regulation of convulsive activity.
authors.affiliation: Department of Neurology, 2nd School of Medicine, Napoli, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Barone
authors.forename: V
authors.initials: V
authors.lastname: Palma
authors.forename: A
authors.initials: A
authors.lastname: DeBartolomeis
authors.forename: E
authors.initials: E
authors.lastname: Tedeschi
authors.forename: G
authors.initials: G
authors.lastname: Muscettola
authors.forename: G
authors.initials: G
authors.lastname: Campanella
mesh_terms: D000818:Animals; D001552:Benzazepines / Q000494:pharmacology* / Q000627:therapeutic use; D018492:Dopamine Antagonists; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D008094:Lithium; D008297:Male; D010862:Pilocarpine; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000502:physiology; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D012640:Seizures / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*
chemical_list: D001552:Benzazepines; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D010862:Pilocarpine; D008094:Lithium